FLORHAM PARK, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity,” “the Company”), a biotechnology company developing placental-derived allogeneic cell therapies and ...

FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial ...

Skin wound healing, especially in chronic non-healing conditions, such as diabetic foot ulcers and infected wounds, remains a formidable clinical challenge due to the complex pathophysiologic ...

Biomaterials with extraordinary properties, such as spider silk, have so far been known primarily from animals. Researchers at the University of Salzburg in Austria have now deciphered a surprising ...

Advanced biomaterials for wound healing encompass a diverse array of engineered constructs designed to interact favourably with the physiological environment, modulate key stages of repair and deliver ...

The biomaterials market is anticipated to expand at a rapid pace due to aging global population and the escalating prevalence of chronic diseases. The biomaterials market is experiencing robust growth ...

Celularity will present benchtop and clinical case studies suggesting the therapeutic potential of its human placental-derived biomaterials at ICBST23, the International Conference on Biomaterials ...